Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes

Neuroscience Research

Volumn 56, Issue 1, 2006, Pages 91-95

  Túnez, Isaac ^a   Montilla, Pedro ^a   Muñoz, M del Carmen ^a   Medina, Francisco J ^a   Drucker Colín, René ^b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

3 Nitropropionic acid; Huntington's disease; Neurodegenerative; Oxidative stress; Succinate dehydrogenase; Transcranial magnetic stimulation

Indexed keywords

3 NITROPROPIONIC ACID; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE PEROXIDASE; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; EVALUATION; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT STRAIN; SYNAPSE; SYNAPTOSOME; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALS; BIOLOGICAL MARKERS; CEREBRAL CORTEX; CONVULSANTS; MALE; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONIC ACIDS; RATS; RATS, WISTAR; SUCCINATE DEHYDROGENASE; SYNAPTOSOMES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33747888536     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.05.012     Document Type: Article

References (46)

1. Aebi H. Catalase in vitro. Meth. Enzymol. 105 (1984) 121-126
2. Agil A., Duran R., Barrero F., Morales B., Arauzo M., Alba F., Miranda M.T., Prieto I., Ramírez M., and Vives F. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa. J. Neurol. Sci. 240 (2006) 31-36
3. Arias-Carrión O., Verdugo-Díaz L., Feria-Velasco A., Millán-Aldaco D., Gutiérrez A.A., Hernández-Cruz A., and Drucker-Colín R. Neurogenesis in the subventricular zone following transcranial magnetic field stimulation and nigro-striatal lesions. J. Neurosci. Res. 78 (2004) 26-28
4. Bickford R.G., Guidi M., Fortesque P., and Swenson M. Magnetic stimulation of human peripheral nerve and brain: response enhancement by combined magnetoelectrical technique. Neurosurgery 20 (1987) 1001-1116
5. Binienda Z.K. Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction. Ann. N. Y. Acad. Sci. 993 (2003) 289-295
6. Bonilla E. Huntington's disease. A Rev. Invest. Clin. 41 (2000) 117-141
7. Borlongan C.V., Koutouzis T.K., Randall T.S., Freeman T.B., Cahill D.W., and Sanberg P.R. Systemic 3-nitrropropionic acid: behavioural deficits and striatal damage in adult rats. Brain Res. Bull. 36 (1995) 147-158
8. Brusa L., Versace V., Koch G., Bernardi G., Iani C., Stanzione P., and Centonze D. Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients. Ann. Neurol. 58 (2005) 655-666
9. Castellani R.J., Lee H.G., Perry G., and Smith M.A. Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. Am. J. Alzheimers Dis. Other Demen. 21 (2006) 126-130
10. Calvo-Merino B., and Haggard P. Transcranial magnetic stimulation. Applications in cognitive neuroscience. Rev. Neurol. 38 (2004) 374-380
11. Christofides J., Bridel M., Egerton M., Mackay G.M., Forrest C.M., Stoy N., Darlington L.G., and Stoy T.W. Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury. J. Neurochem. 97 (2006) 1078-1088
12. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., Daniele A., Ghirlanda S., Gainotti G., and Tonali P.A. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J. Neurol. Neurosurg. Psychiat. 75 (2004) 555-559
13. Drucker-Colín R., Verdugo-Díaz L., Méndez M., Carrillo-Ruíz J., Morgado-Valle C., Hernández-Cruz A., and Corkidi G. Comparison between low frequency magnetic field stimulation and nerve growth factor treatment of cultured chromaffin cells, on neurite growth, noradrenalina release, excitable properties, and grafting in nigrostriatal lesioned rats. Mol. Cell Neurosci. 5 (1994) 485-498
14. Feria-Velasco A., Castillo-Medina S., Verdugo-Díaz L., Castellanos E., Orozco-Suárez S., Sánchez-Gómez C., and Drucker-Colín R. Neuronal differentiation of chromaffin cells in vitro, induced by extremely low frequency magnetic fields or nerve growth factor: a histological and ultra-structural comparative study. J. Neurosci. Res. 53 (1998) 569-582
15. Flohé L., and Gunzler W.A. Assays of glutathione peroxidase. Meth. Enzymol. 105 (1984) 114-121
16. Galbusera C., Facheris M., Magni F., Balimberti G., Sala G., Tremolada L., Isella V., Guerini F.R., Appollonio I., Galli-Kienle M., and Ferrarese C. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Curr. Alzheimer Res. 1 (2004) 103-109
17. Gorczynska E., and Wegrzynowicz R. Structural and functional changes in organelles of liver cells in rats exposed to magnetic fields. Environ. Res. 55 (1991) 188-198
18. Gorczynska E., Galka G., Wegrzynowicz R., and Mikosza H. Effect of magnetic field on the process of cell respiration in mitochondrial of rats. Physiol. Chem. Phys. Med. NMR 18 (1986) 61-69
19. Ihara Y., Takata H., Tanabe Y., Nobukini K., and Hayabara T. Influence of repetitive transcranial magnetic stimulation on disease severity and oxidative stress markers in the cerebrospinal fluid of patients with spinocerebellar degeneration. Neurol. Res. 27 (2005) 310-313
20. Karlstrom E.F., Lundstrom R., Stensson O., and Mild K.H. Therapeutic staff exposure to magnetic field pulses during TMS/rTMS treatment. Bioelectromagnetics 27 (2006) 156-158
21. Kodsi M.H., and Swerdlow N.R. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease. Nuerosci. Lett. 231 (1997) 103-107
22. Kodsi M.H., and Swerdlow N.R. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease. Nuerosci. Lett. 231 (1997) 103-107
23. La Fontaine M.A., Geddes J.W., and Butterfield D.A. 3-Nitropropionic acid-induced changes in bilayer fluidity in synaptosomal membranes: implications for Huntington's disease. Neurochem. Res. 27 (2002) 507-511
24. Lefaucheur J.P., Drouot X., Von Raison F., Menar-Lefaucheur I., Cesaro P., and Nguyen J.P. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clin. Neurophysiol. 115 (2004) 2530-2541
25. Levine R.L., Garland D., Olivier C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Meth. Enzymol. 186 (1990) 464-478
26. Lowry O.H., Rosebrough H.J., Farr A.L., and Randall R.J. Protein measurment with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
27. Mandavilli B.S., Boldogh I., and Van Houten B. 3-Nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Mol. Brain Res. 133 (2005) 215-223
28. Marlatt M., Lee H.G., Perry G., Smith M.A., and Zhu X. Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. Acta Neurobiol. Exp. 64 (2004) 81-87
29. Martin J.B., and Gusella J.F. Huntington's disease: pathogenesis and management. N. Engl. J. Med. 315 (1986) 1267-1276
30. McCracken E., Dewar D., and Hunter A.J. White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat. Brain Res. 892 (2001) 329-335
31. Miniussi C., Bonato C., Bignotti S., Gazzoli A., Gennarelli M., Pasquealetti P., Tura G.B., Ventriglia M., and Rossini P.M. Repetitive transcranial magnetic stimulation (rTMS) at high and low frequency an efficacious therapy for major drug-resistant depression?. Clin Neurophysiol. 116 (2005) 1062-1071
32. Montilla P., Túnez I., Muñoz M.C., Salcedo M., Feijóo M., Muñoz-Castañeda J.R., and Bujalance I. Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes. Eur. J. Pharmacol. 488 (2004) 19-25
33. Pang Z., and Geddes J.W. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute exitotoxic necrosis and delayed apoptosis. J. Neurosci. 17 (1997) 3064-3073
34. Pérez-Severino F., Escalante B., Vegara P., Rios C., and Segovia J. Age-dependent changes in nitric oxide synthase activity and protein expression in strata of mice transgenic for the Huntington's disease mutation. Brain Res. 951 (2002) 36-42
35. Pop L., Muresan M., Comorosan S., and Paslaru L. The effects of pulsed, high frequency radio waves on rat liver (ultrastructural and biomedical observations). Physiol. Chem. Med. NMR 21 (1989) 45-55
36. Post A., Müller M.B., Engelmann M., and Keck E. Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. Eur. J. Neurosci. 11 (1999) 3247-3254
37. Rosenstock T.R., Carvalho A.C., Jurkiewicz A., Frussa-Filho R., and Smaili S.S. Mitochondrial calcium, oxidative stress and apoptosis in neurodegenerative disease model induced by 3-nitropropionic acid. J. Neurochem. 88 (2004) 1220-1228
38. Rossini P.M., and Rossi S. Clinical applications of motor evoked potentials. Electroencephalogr. Clin. Neurophysiol. 106 (1998) 180-194
39. Springere J.E., Azbill R.D., and Carlson S.L. A rapid and sensitive assay for measuring mitochondrial metabolic activity in isolated neural tissue. Brain Res. Protoc. 2 (1997) 259-263
40. Strack A., Duffy C.F., Malvey M., and Arriaga E.A. Individual mitochondrion characterization: a comparison of classical assays to capillary electrophoresis with laser-induced fluorescence detection. Anal. Biochem. 294 (2001) 141-147
41. Tabrizi S.J., Workman J., Mangiarini L., Mahal A., Bates G., Cooper J.M., and Schapira A.H. Mitochondrial dysfunction and free radical damage in Huntington R6/2 transgenic mouse. Ann. Neurol. 47 (2000) 80-86
42. Temur'iants N.A., and Shekhotkin A.V. Changes in the infradian rhythm of the dehydrogenases in the blood lymphocytes of rats due to epiphysectomy and the action of weak alternating magnetic fields. Aviakosm. Ekolog. Med. 29 (1995) 29-43
43. Túnez I., Drucker-Colín R., Jimena I., Medina F.J., Muñoz M.N., Peña J., and Montilla P. Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease. J. Neurochem. J. Neurochem. 97 (2006) 619-630
44. Túnez I., Montilla P., Muñoz M.C., Feijóo M., and Salcedo M. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. J. Pineal Res. 37 (2004) 252-256
45. Túnez I., Montilla P., Muñoz M.C., and Drucker-Colín R. Effect of nicotine on 3-nitropropionic acid-induced oxidative stress insynaptosomes. Eur. J. Pharmacol. 504 (2004) 169-175
46. Verdugo-Díaz L., Palomero M., and Drucker-Colín R. Differentiation of chromaffin cells by extremely low frequency magnetic fields changes ratios of catecholamine type messenger. Bioelectrochem. Bioenerg. 46 (1998) 297-300